EMA — Withdrawn Medicines & Recalls (FDA MedWatch)
EMA — Withdrawn Medicines & Recalls is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.fda.gov
- Country
- United States
- Notices tracked by Mederti
- 2,497
- Last checked
- 1 Aug 2026
Latest notices from FDA MedWatch
- Bd Chloraprep Clear — active, high, since 9 Jul 2026 (source)
- Cleviprex — active, high, since 6 Jul 2026 (source)
- Cinacalcet Hydrochloride Tablets — active, high, since 29 Jun 2026 (source)
- Qc Quality Choice — active, high, since 25 Jun 2026 (source)
- Leader — active, high, since 25 Jun 2026 (source)
- Careone — active, high, since 25 Jun 2026 (source)
- Clinere — active, high, since 25 Jun 2026 (source)
- Family Wellness — active, high, since 25 Jun 2026 (source)
- Bortezomibmannitol — active, high, since 24 Jun 2026 (source)
- Azacitidine Accord 25 Mg / Ml Powder For Suspension For Injection (Azacitidine) — active, high, since 24 Jun 2026 (source)
- Pemetrexed-Disodium — active, high, since 24 Jun 2026 (source)
- Glucagone — active, high, since 23 Jun 2026 (source)
- Duloxetine D/R — active, high, since 22 Jun 2026 (source)
- Carton Label: Testosterone Gel 1% — active, high, since 16 Jun 2026 (source)
- Bd Purprep — active, high, since 11 Jun 2026 (source)
Every FDA MedWatch notice, searchable and alertable
Search United States's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by EMA — Withdrawn Medicines & Recalls. All notices remain the property of their publisher and are linked to the original source.